Altovis
 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (February 2009) (Learn how and when to remove this template message) |
Altovis is a herbal supplement. Its main active ingredients are caffeine and ginseng.[1] Altovis is produced and sold by Berkeley Premium Nutraceuticals (best known for Enzyte),[1] initially via subsidiary Wagner Nutraceuticals.[2]
Overview[edit]
When originally introduced, the active ingredients in Altovis were green tea leaf extract (provides caffeine), cordyceps extract (mycelium), Eleutherococcus (Siberian ginseng), vinpocetine (from vocanga tree seeds), and octacosanol. It also contains the following other ingredients: Dicalcium phosphate, microcrystalline cellulose, croscarmellose sodium, stearic acid, silica, magnesium stearate, and film coat (hypromellose, hydroxypropyl cellulose, polyethylene glycol, propylene glycol, titanium dioxide, FD&C yellow #6 lake, riboflavin, FD&C blue #2 lake).[2]
As of 2008[update], the active ingredients—green tea leaf extract (provides 100 mg caffeine and 350 mg polyphenols), Eleuthero root 12:1 extract (equivalent to 2000 mg eleuthero root), Korean ginseng root 5:1 extract (Panax ginseng), and Octacosanol—have been the same since at least late 2006.[1] The new formula has the same other ingredients, except silica is now listed after magnesium stearate.
References[edit]
- ↑ 1.0 1.1 1.2 Ingredients from the Altovis website archived by the Internet Archive (September 24, 2006)
- ↑ 2.0 2.1 Ingredients from the first Altovis website archived by the Internet Archive (March 25, 2004)
External links[edit]
 | This article about alternative medicine is a stub. You can help EverybodyWiki by expanding it. |
This article "Altovis" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Altovis. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
